Mallinckrodt Receives U.S. FDA Approval for Terlivaz® (terlipressin) for injection for the Treatment of Hepatorenal Syndrome (HRS) ...Middle East

– Terlivaz is the first and only FDA-approved treatment for adults with HRS involving rapid reduction in kidney function1 – DUBLIN, Sept. 14, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, today announced that the U.S. Food and Drug...

Hence then, the article about mallinckrodt receives u s fda approval for terlivaz terlipressin for injection for the treatment of hepatorenal syndrome hrs was published today ( Thursday 15/09/2022 - 05:21 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Mallinckrodt Receives U.S. FDA Approval for Terlivaz® (terlipressin) for injection for the Treatment of Hepatorenal Syndrome (HRS) )

Also on site :

• Nike’s ‘Walkers Tolerated’ sign at the Boston Marathon was meant to fire up runners. Instead, it insulted them
• Amazon Hires Apple’s Oliver Jones For UK Scripted Role
• 'DWTS' Judge Carrie Ann Inaba Speaks Out After Medical Emergency on Plane (Exclusive)